Wynik wyszukiwania w bazie Polska Bibliografia Lekarska GBL

Zapytanie: DZIÓBEK
Liczba odnalezionych rekordów: 1



Przejście do opcji zmiany formatu | Wyświetlenie wyników w wersji do druku
1/1

Tytuł oryginału: Percutaneous mitral valvuloplasty. Long-term clinical and echocardiographic results.
Tytuł polski: Przezskórna walwuloplastyka mitralna. Odległe wyniki kliniczne i echokardiograficzne.
Autorzy: Lekston Andrzej, Gąsior Mariusz, Zębik Tadeusz, Wojnar Rafał, Wilczek Krzysztof, Sikora Jacek, Dzióbek Bogusława, Poloński Lecch, Zembala Marian
Opracowanie edytorskie: Kornacewicz-Jach Zdzisława (koment.), Biederman Andrzej (koment.).
Źródło: Kardiol. Pol. 2002: 56 (5) s.527-537, il., bibliogr. 19 poz. - Tekst równol. w jęz. pol.
Sygnatura GBL: 313,397

Hasła klasyfikacyjne GBL:
  • kardiologia

    Typ dokumentu:
  • praca kliniczna

    Wskaźnik treści:
  • ludzie
  • dorośli 45-64 r.ż.
  • płeć męska
  • płeć żeńska

    Streszczenie angielskie: Background. Rheumatic fever remains the main cause of acquired mitral valve disease, leading to mitral stenosis or insufficiency. Surgical correction has been routinely used to treat this syndrome, however, in some patients it has been replaced by less invasive percutaneous mitral valvuloplasty (PMV). Aim. To assess early and long-term results of PMV. Methods. Sixty one patients (54 females) with mitral valve area = 1.2 cmý, Wilkins scale 10 points and mitral regurgitation 3ř according to Sellers scale underwent PMV using the Inue technique. The mean follow-up duration was 31.4 ń 16.8 months. The control clinical and echocardiographic assessment were performed in 56 (91.8 p.c.) patients (49 females) with a mean age of 55.1 ń 8.7 years. Results. The mitral valve area before PMV was 1.18 ń 0.23 cmý, after the procedure - 1,94 ń 0,21 cmý, and at the long-term follow-up evaluation - 1.76 ń 0.33 cmý. The left atrial diameter was 4.8 ń 0.8 cmý, 4.2 ń 0.7 cmý, and 3.9 ń 0.4 cmý respectively. Following PMV an increase in the degree of mitral regurgitation was observed - in one patient mitral valve replacement was necessary due to grade IV mitral insufficiency. In the other four patients a prosthetic mitral valve was implanted during the follow-up period due to the progression of mitral regurgitation. NYHA class I was achieved by 36 (65 p.c.) patients following the procedure and 28 (50 p.c.) patients during the follow-up period. In NYHA class II were 29 (51 p.c.) patients prior to PMV, 14 (25 pc.) after PMV, and 13 (23 p.c.) during long-term observation...

    stosując format: